Personalized Breast Cancer Treatment
81 – 90 of 142
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer
Lundgren, Christine LU ; Bendahl, Pär-Ola LU ; Ehinger, Anna LU
; Hegardt, Cecilia
LU
; Larsson, Christer
LU
; Loman, Niklas
LU
; Malmberg, Martin
LU
; Olofsson, Helena
; Saal, Lao
LU
and Sjoblom, Tobias
, et al.
(2019)
In Breast Cancer Research and Treatment
p.1-9
- Contribution to journal › Article
-
Mark
Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series
Vallon-Christersson, Johan LU
; Häkkinen, Jari
LU
; Hegardt, Cecilia
LU
; Saal, Lao
LU
; Larsson, Christer
LU
; Ehinger, Anna
LU
; Lindman, H
; Olofsson, Helena
; Sjoblom, Tobias
and Wärnberg, Fredrik
, et al.
(2019)
In Scientific Reports
9.
- Contribution to journal › Article
-
Mark
Refinement of breast cancer molecular classification by miRNA expression profiles
Søkilde, Rolf LU
; Persson, Helena
LU
; Ehinger, Anna
LU
; Pirona, Anna Chiara
; Fernö, Mårten
LU
; Hegardt, Cecilia
LU
; Larsson, Christer
LU
; Loman, Niklas
LU
; Malmberg, Martin
LU
and Rydén, Lisa
LU
, et al.
(2019)
In BMC Genomics
20(1).
- Contribution to journal › Article
-
Mark
Distribution of Locoregional Breast Cancer Recurrence in Relation to Postoperative Radiation Fields and Biological Subtypes
- Contribution to journal › Article
-
Mark
Expression of HIF-1α is related to a poor prognosis and tamoxifen resistance in contralateral breast cancer
Jögi, Annika LU ; Ehinger, Anna LU
; Werner Hartman, Linda
LU
and Alkner, Sara
LU
(2019)
In PLoS ONE
14(12).
- Contribution to journal › Article
-
Mark
Clinicogenomic radiotherapy classifier predicting the need for intensified locoregional treatment after breast-conserving surgery for early-stage breast cancer
Sjöström, Martin LU ; Laura Chang, S. ; Fishbane, Nick ; Davicioni, Elai ; Zhao, Shuang G. ; Hartman, Linda LU
; Holmberg, Erik
; Feng, Felix Y.
; Speers, Corey W.
and Pierce, Lori J.
, et al.
(2019)
In Journal of Clinical Oncology
37(35).
p.3340-3349
- Contribution to journal › Article
- 2018
-
Mark
Stability of oestrogen and progesterone receptor antigenicity in formalin‐fixed paraffin‐embedded breast cancer tissue over time
Ehinger, Anna LU
; Bendahl, Pär-Ola
LU
; Rydén, Lisa
LU
; Fernö, Mårten
LU
and Alkner, Sara
LU
(2018)
In APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
126(9).
p.746-754
- Contribution to journal › Article
-
Mark
Assessment of early response biomarkers in relation to long-term survival in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy plus bevacizumab : Results from the Phase II PROMIX trial
Kimbung, Siker LU ; Markholm, Ida ; Bjöhle, Judith ; Lekberg, Tobias ; Wachenfeldt, von Anna ; Azavedo, Edward ; Saracco, Ariel ; Hellström, Mats ; Veerla, Srinivas LU
and Paquet, Eric
, et al.
(2018)
In International Journal of Cancer
142(3).
p.618-628
- Contribution to journal › Article
-
Mark
Immune gene expression and response to chemotherapy in advanced breast cancer
- Contribution to journal › Article
-
Mark
Abstract P3-02-02: Concordance between immunohistochemical and gene-expression based subtyping of early breast cancer using core needle biopsies and surgical specimens - experices from SCAN-B
Morgan, G ; Larsson, Christer LU ; Tahin, Balázs ; Vallon-Christersson, Johan LU
; Häkkinen, Jari
LU
; Ehinger, Anna
LU
; Malmberg, Martin
LU
; Hegardt, Cecilia
LU
; Borg, Åke
LU
and Rydén, Lisa
LU
, et al.
(2018)
San Antonio Breast Cancer Symposium, 2017
In Cancer research. Supplement
78(4).
- Contribution to journal › Published meeting abstract